Alliance Healthcare Group Limited (SGX:MIJ)
Singapore · Delayed Price · Currency is SGD 0.1880
0.00 (0.00%)
At close: Sep 11, 2026
Alliance Healthcare Group Ratios and Metrics
Market cap in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 39 | 34 | 23 | 29 | 36 | 35 | |
Market Cap Growth | 43.85% | 48.53% | -21.27% | -19.92% | 1.84% | -1.13% |
Enterprise Value | 36 | 30 | 24 | 30 | 29 | 28 |
Last Close Price | 0.19 | 0.16 | 0.11 | 0.14 | 0.17 | 0.16 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 10.77 | 9.33 | 14.90 | 40.06 | 17.22 | 11.36 |
PS Ratio | 0.45 | 0.39 | 0.29 | 0.42 | 0.62 | 0.65 |
PB Ratio | 1.39 | 1.21 | 0.94 | 1.25 | 1.52 | 1.48 |
P/TBV Ratio | 2.00 | 1.73 | 1.35 | 1.81 | 2.13 | 2.21 |
P/FCF Ratio | 4.11 | 3.56 | 4.44 | 14.11 | 207.45 | 3.76 |
P/OCF Ratio | 3.71 | 3.22 | 3.95 | 6.45 | 14.58 | 3.60 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.41 | 0.35 | 0.31 | 0.44 | 0.50 | 0.52 |
EV/EBITDA Ratio | 3.78 | 4.91 | 6.77 | 13.55 | 9.13 | 5.21 |
EV/EBIT Ratio | 8.26 | 7.07 | 12.55 | 35.27 | 11.45 | 5.91 |
EV/FCF Ratio | 3.83 | 3.22 | 4.70 | 14.53 | 166.81 | 3.02 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.64 | 0.64 | 0.75 | 0.91 | 0.58 | 0.36 |
Debt / EBITDA Ratio | 1.89 | 1.89 | 2.71 | 4.32 | 2.74 | 1.19 |
Debt / FCF Ratio | 1.90 | 1.90 | 3.51 | 10.22 | 79.89 | 0.92 |
Net Debt / Equity Ratio | -0.11 | -0.11 | 0.06 | 0.10 | -0.24 | -0.50 |
Net Debt / EBITDA Ratio | -0.51 | -0.51 | 0.43 | 1.02 | -1.79 | -2.22 |
Net Debt / FCF Ratio | -0.34 | -0.34 | 0.30 | 1.10 | -32.76 | -1.28 |
Asset Turnover | 0.90 | 0.90 | 0.89 | 0.92 | 1.00 | 1.09 |
Inventory Turnover | 18.17 | 18.17 | 16.65 | 17.10 | 17.63 | 19.20 |
Quick Ratio | 1.11 | 1.11 | 1.08 | 0.98 | 1.32 | 1.47 |
Current Ratio | 1.18 | 1.18 | 1.18 | 1.06 | 1.47 | 1.62 |
Return on Equity (ROE) | 13.38% | 13.38% | 4.66% | 1.50% | 8.43% | 19.38% |
Return on Assets (ROA) | 2.78% | 2.78% | 1.38% | 0.71% | 2.71% | 5.95% |
Return on Invested Capital (ROIC) | 15.85% | 15.59% | 7.04% | 3.89% | 15.77% | 32.41% |
Return on Capital Employed (ROCE) | 11.80% | 11.80% | 5.60% | 2.90% | 7.60% | 16.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 9.29% | 10.72% | 6.71% | 2.50% | 5.81% | 8.80% |
FCF Yield | 24.34% | 28.07% | 22.51% | 7.09% | 0.48% | 26.57% |
Dividend Yield | 2.89% | 3.19% | 0.92% | - | 1.76% | 2.77% |
Payout Ratio | 5.71% | 5.71% | - | 85.76% | 44.28% | 15.36% |
Buyback Yield / Dilution | -0.38% | -0.38% | -0.15% | -0.02% | 0.88% | 0.12% |
Total Shareholder Return | 2.51% | 2.81% | 0.76% | -0.02% | 2.64% | 2.90% |